| Old Articles: <Older 17971-17980 Newer> |
|---|
 |
The Motley Fool
November 1, 2006
Rich Duprey |
A KO for K2 in Q3 The sporting-goods manufacturer continues to show strength in its winter-sports lines. K2 has the potential to have knockout quarters every quarter because it does own leading brands in a variety of sports that rise to prominence at different times during the year. Investors, take note.   |
The Motley Fool
November 1, 2006 |
No Chinks in This Under Armour: Fool by Numbers The athletic clothier released its first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
November 1, 2006
Rick Aristotle Munarriz |
Blockbuster's Brazen Bet In a move that may sound as brilliant as it is desperate, Blockbuster is now allowing its online customers the ability to walk into their nearest store and exchange a rented DVD for another title. Investors, take note. |
The Motley Fool
November 1, 2006
Rick Aristotle Munarriz |
Drawn to DreamWorks This stock has gone nowhere. The playing field is crowded. Direct-to-video is drying up as a major release outlet. What's an investor to do? Its third-quarter profit is just the beginning of a possible upswing. |
The Motley Fool
November 1, 2006
Tim Beyers |
Earn Life-Changing Returns Cuddling up to the best growth stocks while they're still young can make you richer than you might think. optionsXpress... CoTherix... Google... iRobot... The9... Nextest Systems... etc. |
The Motley Fool
November 1, 2006 |
Biogen Idec's Bill of Health: Fool by Numbers The biotech released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
November 1, 2006
Rick Aristotle Munarriz |
Baidu Is More Buy Than Due China's search leader sets the right tone in the third quarter. Investors, take note. |
The Motley Fool
November 1, 2006
Brian Lawler |
Biogen Idec's Booming Results Even with guidance for 2006 non-GAAP earnings per share raised to more than $2.20, Biogen shares are trading at a reasonable 24 times earnings, considering the level of scale and sales growth it has exhibited this year. |
The Motley Fool
November 1, 2006 |
Analyzing Agere: Fool by Numbers The mobile communications specialist released fourth-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
November 1, 2006
Rick Aristotle Munarriz |
Burning Down the HouseValues HouseValues brings down the roof again. The company's investments into real estate listings and mortgage referrals is problematic in that it ties itself to a sector that may not be bouncing back anytime soon. Investors, take note. |
| <Older 17971-17980 Newer> Return to current articles. |
